Literature DB >> 30108761

Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agents.

Chandradhish Ghosh1, Shweta Chaubey2, Utpal Tatu2, Jayanta Haldar1.   

Abstract

Due to emerging resistance there is a steady need for new antimalarial drugs. Here, we report a new class of water soluble, non-toxic compounds, aryl-alkyl-lysines, with promising activity against the ring stage of Plasmodium falciparum. The optimal compound perturbed the plasma membrane potential and the digestive vacuole of parasites. In the murine model of malaria (Plasmodium berghei ANKA) the compound was able to increase the survival of mice by at least 5 days by an intra-peritoneal route. Further, the compounds showed no apparent toxicity to mice at the concentration tested.

Entities:  

Year:  2016        PMID: 30108761      PMCID: PMC6071861          DOI: 10.1039/c6md00589f

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  29 in total

1.  Identification of peptides targeting the surface of Plasmodium falciparum-infected erythrocytes using a phage display peptide library.

Authors:  Keiko Eda; Shigetoshi Eda; Irwin W Sherman
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

2.  Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria.

Authors:  Ariel H Achtman; Sandra Pilat; Charity W Law; David J Lynn; Laure Janot; Matt L Mayer; Shuhua Ma; Jason Kindrachuk; B Brett Finlay; Fiona S L Brinkman; Gordon K Smyth; Robert E W Hancock; Louis Schofield
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

3.  Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.

Authors:  Romanico B G Arrighi; Charles Ebikeme; Yang Jiang; Lisa Ranford-Cartwright; Michael P Barrett; Ulo Langel; Ingrid Faye
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

Review 4.  Multifunctional host defense peptides: antiparasitic activities.

Authors:  Amram Mor
Journal:  FEBS J       Date:  2009-10-09       Impact factor: 5.542

5.  Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.

Authors:  R W Gwadz; D Kaslow; J Y Lee; W L Maloy; M Zasloff; L H Miller
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology.

Authors:  Julien Guergnon; Frédéric Dessauge; Victoria Dominguez; Jean Viallet; Serge Bonnefoy; Victor J Yuste; Odile Mercereau-Puijalon; Xavier Cayla; Angelita Rebollo; Santos A Susin; Pierre-Etienne Bost; Alphonse Garcia
Journal:  Mol Pharmacol       Date:  2005-12-30       Impact factor: 4.436

7.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Authors:  Christoph Gelhaus; Thomas Jacobs; Jörg Andrä; Matthias Leippe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

Review 9.  Primaquine revisited six decades after its discovery.

Authors:  Nuno Vale; Rui Moreira; Paula Gomes
Journal:  Eur J Med Chem       Date:  2008-09-11       Impact factor: 6.514

10.  Spread of artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Elizabeth A Ashley; Mehul Dhorda; Rick M Fairhurst; Chanaki Amaratunga; Parath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Sivanna Mao; Baramey Sam; Chantha Sopha; Char Meng Chuor; Chea Nguon; Siv Sovannaroth; Sasithon Pukrittayakamee; Podjanee Jittamala; Kesinee Chotivanich; Kitipumi Chutasmit; Chaiyaporn Suchatsoonthorn; Ratchadaporn Runcharoen; Tran Tinh Hien; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Nguyen Hoan Phu; Ye Htut; Kay-Thwe Han; Kyin Hla Aye; Olugbenga A Mokuolu; Rasaq R Olaosebikan; Olaleke O Folaranmi; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Paul N Newton; Marie A Onyamboko; Caterina I Fanello; Antoinette K Tshefu; Neelima Mishra; Neena Valecha; Aung Pyae Phyo; Francois Nosten; Poravuth Yi; Rupam Tripura; Steffen Borrmann; Mahfudh Bashraheil; Judy Peshu; M Abul Faiz; Aniruddha Ghose; M Amir Hossain; Rasheda Samad; M Ridwanur Rahman; M Mahtabuddin Hasan; Akhterul Islam; Olivo Miotto; Roberto Amato; Bronwyn MacInnis; Jim Stalker; Dominic P Kwiatkowski; Zbynek Bozdech; Atthanee Jeeyapant; Phaik Yeong Cheah; Tharisara Sakulthaew; Jeremy Chalk; Benjamas Intharabut; Kamolrat Silamut; Sue J Lee; Benchawan Vihokhern; Chanon Kunasol; Mallika Imwong; Joel Tarning; Walter J Taylor; Shunmay Yeung; Charles J Woodrow; Jennifer A Flegg; Debashish Das; Jeffery Smith; Meera Venkatesan; Christopher V Plowe; Kasia Stepniewska; Philippe J Guerin; Arjen M Dondorp; Nicholas P Day; Nicholas J White
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

View more
  2 in total

1.  Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.

Authors:  Thomas R Lane; Christopher Massey; Jason E Comer; Alexander N Freiberg; Huanying Zhou; Julie Dyall; Michael R Holbrook; Manu Anantpadma; Robert A Davey; Peter B Madrid; Sean Ekins
Journal:  Antiviral Res       Date:  2020-07-16       Impact factor: 5.970

2.  Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection.

Authors:  Chandradhish Ghosh; Ahmed AbdelKhalek; Haroon Mohammad; Mohamed N Seleem; Jayanta Haldar
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.